These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30542181)

  • 1. Designer viruses could be the secret to cheaper and better gene therapy.
    Savage N
    Nature; 2018 Dec; 564(7735):S18-S19. PubMed ID: 30542181
    [No Abstract]   [Full Text] [Related]  

  • 2. Vector decoys trick the immune response.
    VandenDriessche T; Chuah MK
    Sci Transl Med; 2013 Jul; 5(194):194fs28. PubMed ID: 23863831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Platform Vector Gene Therapies Project: Increasing the Efficiency of Adeno-Associated Virus Gene Therapy Clinical Trial Startup.
    Brooks PJ; Ottinger EA; Portero D; Lomash RM; Alimardanov A; Terse P; Xu X; Chandler RJ; Geist Hauserman J; Esposito E; Bönnemann CG; Venditti CP; Austin CP; Pariser A; Lo DC
    Hum Gene Ther; 2020 Oct; 31(19-20):1034-1042. PubMed ID: 32993373
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing the adeno-associated viral vector system: a brief summary.
    Hacker U; Büning H
    Ther Deliv; 2011 Aug; 2(8):967-70. PubMed ID: 22826865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy: Industrial strength.
    Bender E
    Nature; 2016 Sep; 537(7619):S57-9. PubMed ID: 27602741
    [No Abstract]   [Full Text] [Related]  

  • 7. The consortium project to treat RPE65 deficiency in humans.
    Hauswirth WW
    Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
    [No Abstract]   [Full Text] [Related]  

  • 8. Adeno-associated virus vectors for gene therapy: more pros than cons?
    Monahan PE; Samulski RJ
    Mol Med Today; 2000 Nov; 6(11):433-40. PubMed ID: 11074369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic shortcut to antibody drugs.
    Keener A
    Nature; 2018 Dec; 564(7735):S16-S17. PubMed ID: 30542196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy using AAV (adeno-associated virus) vectors].
    Ozawa K
    Uirusu; 2003 Dec; 53(2):163-70. PubMed ID: 15080081
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene Therapy Briefs.
    Philippidis A
    Hum Gene Ther Clin Dev; 2018 Mar; 29(1):1-6. PubMed ID: 29641280
    [No Abstract]   [Full Text] [Related]  

  • 12. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.
    Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF
    Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to AAV capsid: are mice not humans after all?
    Herzog RW
    Mol Ther; 2007 Apr; 15(4):649-50. PubMed ID: 17372595
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure of adeno-associated virus serotype 8, a gene therapy vector.
    Nam HJ; Lane MD; Padron E; Gurda B; McKenna R; Kohlbrenner E; Aslanidi G; Byrne B; Muzyczka N; Zolotukhin S; Agbandje-McKenna M
    J Virol; 2007 Nov; 81(22):12260-71. PubMed ID: 17728238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies.
    Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L
    Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response.
    Herzog RW
    Mol Ther; 2015 Sep; 23(9):1411-2. PubMed ID: 26321180
    [No Abstract]   [Full Text] [Related]  

  • 17. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.
    Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ
    Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.
    Pekrun K; De Alencastro G; Luo QJ; Liu J; Kim Y; Nygaard S; Galivo F; Zhang F; Song R; Tiffany MR; Xu J; Hebrok M; Grompe M; Kay MA
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization and application of adeno-associated virus serotype 8 as a gene transfer vector].
    Wang G; Wu XB
    Bing Du Xue Bao; 2011 Jan; 27(1):91-5. PubMed ID: 21462514
    [No Abstract]   [Full Text] [Related]  

  • 20. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods.
    Palaschak B; Herzog RW; Markusic DM
    Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.